Clinical Trial Update: Fenretinide in Treating Patients With Leukoplakia of the Mouth [Phase 2]

View source ↗

Summary

Phase 2 trial of fenretinide for oral leukoplakia has completed; the snippet does not provide the trial results. Status indicates completion but results are not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Leukoplakia

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED